N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine

Term ID

CHEBI:50670

Synonyms

2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranose
2-acetamido-4-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-2-deoxy-beta-D-glucopyranose
beta-D-GlcNAc-(1->4)-beta-D-GlcNAc
beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc
beta-di-N-acetylchitobiose
betaGlcNAc(1->4)betaGlcNAc
DI(N-ACETYL-D-GLUCOSAMINE)
GlcNAcb1-4GlcNAcb
GlcNAcbeta1-4GlcNAcbeta
N,N'-diacetylchitobiose
WURCS=2.0/1,2,1/[a2122h-1b_1-5_2*NCC/3=O]/1-1/a4-b1

(all 11)

Definition

An N,N'-diacetylchitobiose having beta-configuration at the reducing end anomeric centre.

References

(all 15)

Ontology

ChEBI ( EBI )

Relationships

is a type of: N,N'-diacetylchitobiose

N,N'-diacetylchitobiose Show first 5 Terms
has_functional_parent: beta-D-glucosaminyl-(1->4)-beta-D-glucosamine

beta-D-glucosaminyl-(1->4)-beta-D-glucosamine Show first 5 Terms
has_role: epitope

epitope Show first 5 Terms
inverse has_functional_parent: alpha-L-Fucp-(1->6)-[beta-D-GlcpNAc-(1->4)]-beta-D-GlcNAc beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc beta-D-GlcpNAc-(1->4)-[beta-D-Manp-(1->6)]-beta-D-GlcpNAc beta-D-GlcpNAc-(1->4)-[beta-L-Fucp-(1->6)]-beta-D-GlcpNAc

alpha-L-Fucp-(1->6)-[beta-D-GlcpNAc-(1->4)]-beta-D-GlcNAc beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc beta-D-GlcpNAc-(1->4)-[beta-D-Manp-(1->6)]-beta-D-GlcpNAc beta-D-GlcpNAc-(1->4)-[beta-L-Fucp-(1->6)]-beta-D-GlcpNAc Show first 5 Terms
inverse is_substituent_group_from: N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosaminyl group

N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosaminyl group Show first 5 Terms

Phenotype

Phenotype resulting from N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine

Phenotype where environments contain N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine

Phenotype modified by environments containing N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine

Phenotype affecting N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine

Human Disease Model